Here’s What Russians Hoarded When the Lockdown Began

(Bloomberg) — While consumers around the globe were hoarding toilet paper last month ahead of a wave of government-imposed lockdowns, Russians were stockpiling cash.About 1 trillion rubles ($13.6 billion) has been issued from cash machines and bank branches since the beginning of March, more than during the whole of last year, central bank data show.“People…

Wells Fargo: 2 Big 13% Dividend Stocks to Buy (And 1 to Avoid)

After almost 4 weeks of bullish trading, investors are growing used to the idea that we’re in a true rally. Yes, markets are still down from their February peak; yes, the coronavirus epidemic is still going strong; and yes, the lockdowns in place to combat the virus’ spread are still wreaking havoc on the economy…

Gilead Shares Rise On Early Peek At Positive Covid-19 Vaccine Data

Gilead Sciences (GILD) shares popped over 16% in after-hours trading on Thursday following encouraging anecdotal data from Gilead’s remdesivir COVID-19 trials.News source STAT reported on a video presentation within a single site, the University of Chicago, which recruited 125 COVID-19 patients into GILD’s phase III trials.According to the presentation, only 2 of the 113 severe…

3 Frontrunners In COVID-19 Vaccine Development: What You Need To Know

As companies race against time to bring to market a vaccine for the new coronavirus — SARS-CoV-2 — that causes COVID-19, three contenders have emerged as frontrunners, having advanced their candidates into the clinics.Moderna Inc (NASDAQ: MRNA), Inovio Pharmaceuticals Inc (NASDAQ: INO) and CanSino Biological Inc./Beijing Institute of Biotechnology are those that have moved out…

Gilead Sciences’ Remdesivir Could Be the Silver Bullet That Kills Coronavirus — But Can It Make Money?

Remdesivir, the Gilead Sciences (GILD) drug also known as "GS-5734," and originally developed as a treatment for Ebola, has been hailed as perhaps the best hope (currently under investigation) to help stop the spread of the SARS-CoV-2 coronavirus.Remdesivir is currently undergoing the fastest of fast-track authorizations to develop the drug and test its effectiveness against…

Fear of an Impending Car-Price Collapse Grips Auto Industry

(Bloomberg) — The auto industry — already fretting lengthy factory shutdowns and depressed new-vehicle demand — is starting to sound the alarm about a potential used-car price collapse that could have far-reaching consequences for manufacturers, lenders and rental companies.Used-vehicle auctions are for now virtually paralyzed, much like the rest of the economy. The grave concern…

The Race Continues for a COVID-19 Vaccine; 3 Healthcare Stocks to Watch

The question keeping the world up at night: when will a COVID-19 vaccine be ready? Since China released the virus’ genetic sequence on January 10, researchers in several countries have been working around the clock to develop an effective and safe vaccine. Even though the rapid pace of the development process has been impressive to…